Please try another search
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.
Name | Age | Since | Title |
---|---|---|---|
Antonio Bertoletti | - | 2020 | Member of Scientific Advisory Board |
Patrick Kennedy | - | 2020 | Member of Scientific Advisory Board |
Tomas Cihlar | - | 2023 | Director |
Anthony E. Altig | 68 | 2012 | Independent Director |
Adam Zlotnick | - | 2014 | Co-Founder, Chief Scientific Advisor and Chair of Hbv & Virology Science Advisory Board |
William R. Ringo | 79 | 2014 | Independent Non-Executive Chairman |
Lisa R. Johnson-Pratt | 60 | 2021 | Independent Director |
Michael Houghton | 73 | 2021 | Member of Scientific Advisory Board & Independent Director |
Stephan Urban | - | 2020 | Member of Scientific Advisory Board |
Jason A. Okazaki | 48 | 2020 | CEO, President & Director |
Robert Donald Cook | 65 | 2024 | Director |
Gina R. Consylman | 51 | 2020 | Independent Director |
John G. McHutchison | 66 | 2019 | Director |
Tomas Cihlar | 57 | 2023 | Director |
Susan M. Mahony | 60 | 2017 | Independent Director |
Alex Thompson | - | 2020 | Member of Scientific Advisory Board |
Edward J. Gane | - | 2020 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review